Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Dec;75(6):1274-1277.
doi: 10.1016/j.jaad.2016.09.015. Epub 2016 Oct 4.

Diffuse atrophic papules and plaques, intermittent abdominal pain, paresthesias, and cardiac abnormalities in a 55-year-old woman

Affiliations
Case Reports

Diffuse atrophic papules and plaques, intermittent abdominal pain, paresthesias, and cardiac abnormalities in a 55-year-old woman

Brittany Oliver et al. J Am Acad Dermatol. 2016 Dec.

Abstract

KEY TEACHING POINTS.

Keywords: Degos disease; complement; eculizumab; interferon; malignant atrophic papulosis; treprostinil; vasculopathy.

PubMed Disclaimer

Conflict of interest statement

No other potential conflicts of interest relevant to this article were reported.

Figures

Figure 1
Figure 1
Malignant atrophic papulosis. (A) Porcelain white, irregularly shaped atrophic papules and plaques with erythematous, telangiectatic rim on the abdomen. (B) Close-up view of atrophic papules.
Figure 1
Figure 1
Malignant atrophic papulosis. (A) Porcelain white, irregularly shaped atrophic papules and plaques with erythematous, telangiectatic rim on the abdomen. (B) Close-up view of atrophic papules.
Figure 2
Figure 2
Dermatopathology of malignant atrophic papulosis. Lichenoid dermatitis with hyperkeratosis, patchy lymphocytic infiltrate, hemosiderin deposition, increased dermal mucin, and colloid bodies in the superficial dermis. (A) H&E, ×40; (B) H&E, ×400).
Figure 2
Figure 2
Dermatopathology of malignant atrophic papulosis. Lichenoid dermatitis with hyperkeratosis, patchy lymphocytic infiltrate, hemosiderin deposition, increased dermal mucin, and colloid bodies in the superficial dermis. (A) H&E, ×40; (B) H&E, ×400).

References

    1. Katz SK, Mudd LJ, Roenigk HH. Malignant atrophic papulosis (Degos’ disease) involving three generations of a family. J Am Acad Dermatol. 1997;37:480–484. - PubMed
    1. Scheinfeld N. Malignant atrophic papulosis. Clin Exp Dermatol. 2007;32:483–487. - PubMed
    1. Heymann WR. Degos disease: Considerations for reclassification. J Am Acad Dermatol. 2009;61:505–506. - PubMed
    1. Magro CM, Poe JC, Kim C, Shapiro L, Nuovo G, Crow MK, et al. Degos disease: a C5b-9/Interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol. 2011;135(4):599–610. - PubMed
    1. Barlow RJ, Heyl T, Simson IW, Schulz EJ. Malignant atrophic papulosis (Degos’ disease) – diffuse involvement of brain and bowel in an African patient. Br J Dermatol. 1988;118:117–123. - PubMed

Publication types

MeSH terms